↓ Skip to main content

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

Overview of attention for article published in BMC Musculoskeletal Disorders, December 2013
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
99 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
Published in
BMC Musculoskeletal Disorders, December 2013
DOI 10.1186/1471-2474-14-350
Pubmed ID
Authors

Marloes Vermeer, Wietske Kievit, Hillechiena H Kuper, Louise MA Braakman-Jansen, Hein J Bernelot Moens, Theo R Zijlstra, Alfons A den Broeder, Piet LCM van Riel, Jaap Fransen, Mart AFJ van de Laar

Abstract

Where health economic studies are frequently performed using modelling, with input from randomized controlled trials and best guesses, we used real-life data to analyse the cost-effectiveness and cost-utility of a treatment strategy aiming to the target of remission compared to usual care in early rheumatoid arthritis (RA).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Netherlands 1 1%
Colombia 1 1%
Brazil 1 1%
Canada 1 1%
Unknown 93 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 19%
Student > Ph. D. Student 16 16%
Student > Master 14 14%
Other 9 9%
Student > Bachelor 7 7%
Other 21 21%
Unknown 13 13%
Readers by discipline Count As %
Medicine and Dentistry 47 47%
Psychology 6 6%
Nursing and Health Professions 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Agricultural and Biological Sciences 3 3%
Other 13 13%
Unknown 20 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2013.
All research outputs
#17,706,524
of 22,736,112 outputs
Outputs from BMC Musculoskeletal Disorders
#2,887
of 4,032 outputs
Outputs of similar age
#223,357
of 307,365 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#54
of 87 outputs
Altmetric has tracked 22,736,112 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,032 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,365 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.